News
April 17, 2024
ADAI in the News
ADAI’s Caleb Banta-Green, PhD, MPH, MSW, Director of the Center for Community Engaged Drug Epidemiology, Education & Research (CEDEER), was featured in two news articles in the past week: A sliver of hope in a record-setting year of deaths of homeless people. Seattle Times, April 17, 2024. (free link)Fentanyl-related fatal overdoses continue to devastate King County’s…
January 24, 2024
New from CERP: Personal Experiences with High-THC Cannabis
Twenty years ago, most cannabis contained 10% or less THC, and anything higher was considered very potent. Today, cannabis flower (the plant) can be as high as 25% THC, and other cannabis products contain as much as 60-90%. Cannabis concentrates, such as shatter, wax, vaping cartridges, dabs, and butters, made up 35% of the Washington…
August 4, 2023
ADAI In the News: A Round-Up of Stories on Xylazine, Fentanyl, Meth Overdose, “Health Hubs,” and More!
ADAI faculty and staff have been featured in a lot of news articles and other media lately. Here’s a round-up of some of the pieces and podcasts. (Want to be the first to know when ADAI folks are in the media? Follow us on X/Twitter!) Xylazine or “tranq” in WA: Rising drug threat or an…
July 6, 2023
New Podcast Episode Featuring Dr. Mandy Owens: Substance Use and The Reentry Process
This week, ADAI Assistant Professor Mandy Owens, PhD was interviewed on the More Life: The Reentry Podcast by host VanKe’via Garner, MS to talk about the intersection of substance use disorders and the criminal legal system. For people with a substance use disorder (SUD), reentry after jail or prison can be a particularly dangerous time….
March 29, 2023
NEW: U.S. FDA Approves Narcan (4mg Naloxone Nasal Spray) for Over-The-Counter Purchase/Use
From the US FDA press release: Today, the U.S. Food and Drug Administration approved Narcan, 4 milligram (mg) naloxone hydrochloride nasal spray for over-the-counter (OTC), nonprescription, use – the first naloxone product approved for use without a prescription. Naloxone is a medication that rapidly reverses the effects of opioid overdose and is the standard treatment…
February 15, 2023
ADAI in the News: Dr. Caleb Banta-Green on Over-the-Counter Naloxone and Low-Barrier Treatment
ADAI Acting Professor Caleb Banta-Green, PhD, MPH, MSW recently talked with Scripps National News about making the opioid overdose antidote naloxone available over-the-counter (OTC). The FDA is meeting today (Feb. 15, 2023) to review the application for an OTC version of naloxone nasal spray. Though the goal of such a move would be to expand…
December 21, 2022
Taking Stock of WA State’s Decade of Legal Cannabis (KUOW, featuring ADAI’s Beatriz Carlini)
In this piece, KUOW’s Amy Radil provides information about the path legal cannabis has taken in Washington over the last 10 years and where it appears to be headed in the future. ADAI Director of the Cannabis Education & Research Program, Dr. Beatriz Carlini, is featured in the article, taking about risks associated with use…
December 1, 2022
Substance Use is a Health Issue, Not a Legal One – Op-Ed in the Seattle Times by Dr. Caleb Banta-Green
See also: December 2, 2022 KUOW interview with Dr. Banta-Green about the ongoing rise in fentanyl-related deaths and need for treatment options. ADAI Acting Professor Caleb Banta-Green, PhD authored an opinion piece published in the Seattle Times on November 30, 2022 urging the Washington State Legislature and governor to act on recommendations made by the…
November 10, 2022
Looking for ADAI Events?
Looking for upcoming events hosted by the UW Addictions, Drug & Alcohol Institute? You can find our events a few different ways: Subscribe to the ADAI News & Events blog (this!) and get notices about events hosted by ADAI and its various centers and teams (CEDEER, CAAHS and the Northwest ATTC, CERP, CTN, and more!),…
November 4, 2022
How Can We Solve King County’s Fentanyl Problem? Seattle Met Article Feat. Caleb Banta-Green
Seattle Met magazine has two new stories about fentanyl in King County, both by Angela Cabotaje. The first, “How Can We Solve King County’s Fentanyl Problem?,” features ADAI Acting Professor Caleb Banta-Green, PhD, MPH, MSW, describing the impact pharmaceutical companies had on the opioid overdose crisis, and the innovative program Bupe Pathways, which is helping…
Next page
